Latest Updates
-
Chhath Puja 2026: Dates, Four-Day Rituals, Significance and Surya Arghya Timings -
Kavya Maran and Anirudh Ravichander Tie the Knot in Greece, Couple Shares Post -
Who Is Kimberly Powell? Meet Nvidia's Healthcare Chief Named in Fresh Jensen Huang Allegations -
5 Must-Read Books on Spirituality and Personal Growth to Start 2027 on a Positive Note -
Kareena Kapoor Khan's Bhopal Royal Pendant Look Sparks Debate Amid Legal Notice -
High Blood Pressure: The Silent Health Risk You Should Never Ignore -
OTT Releases This Week: Jailer 2, Daayra, Ranabaali, The Rings of Power Season 3 and More -
Yami Gautam as Maa Sita? Reddit Debate Heats Up After Ramayana Release -
Diwali 2026: When to Perform Lakshmi Puja? Check Auspicious Timings for Your City by Astrologer -
Diwali 2026 Astrology Predictions: 4 Zodiac Signs May Shine While 4 Need to Stay Alert
Scorpion Venom May Help Fight Brain Cancer

Researchers have found a brain-cancer therapy which uses a radioactive version of a protein found in scorpion venom. Traditional treatments like radiation and chemotherapy kill healthy cells in the process of controlling the cancer growth.
The sting of the scorpion Leiurus quinquestriatus unleashes a cocktail of neurotoxins containing a peptide that is non-toxic to humans but binds to tumour cells. In tests, the peptide has invaded tumours in breast, skin, brain and lung tissue while leaving healthy cells untouched.
"It's as if the tumours collect it," New Scientist quoted Michael Egan of the company TransMolecular in Cambridge, Massachusetts, as saying.
To determine if the peptide could deliver lethal doses of radioactivity to cancer cells, researchers have now attached radioactive iodine isotopes to it.
In an experiment, the researchers injected this agent directly into the tumours of 59 people suffering from inoperable brain cancer. All the patients have now died, but those receiving a higher dose lived for three months longer, on average.
Researchers at the University of Chicago in Illinois have begun injecting TM601 into the bloodstream of people with different types of malignant brain cancer. This latest trial will allow the company to test whether it can seek out and kill secondary tumours throughout the body, as well as known primary ones.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications
